AMSBIO has extended its COVID-19 research portfolio with the introduction of a service to provide custom lentivirus pseudotyped with spike glycoprotein from SARS-CoV-2 to help researchers identify potential targets for development of therapeutic drugs and vaccines. Various research groups around the world have demonstrated that SARS-CoV-2 uses its spike glycoprotein S, a main target for neutralization […]
NEWARK, Calif. — Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announced the launch of its new website providing fresh information about Intabio’s Blaze™ iCIEF-MS system. The new website features updated product information and a detailed look into Blaze’s proprietary microchip-based technology. Commercial launch […]
– Functional Antibodies Identified to S1 Spike Protein and ACE2 Cellular Receptor – SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (Nasdaq: TWST) today reported it has identified competitive antibodies to SARS-CoV-2, the virus that causes COVID-19, which could potentially be used for diagnostic tests or therapeutic treatments. Twist’s unique monoclonal antibody candidates bind with high affinity to […]
Highest level of AOAC approval includes testing for foods such as romaine lettuce, raw salmon, dairy products and herbs and spices WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its Solus One™ Salmonella assay and methods have been granted First Action Official Methods of AnalysisSM (OMA) status, number 2020.03, […]
EDINBURGH – Arrayjet Limited, the Scottish-based bio-printing technology specialist for the life sciences industry, has re-purposed its in-house antibody screening technology to create a population-scale diagnostic programme that will help scientists better understand the behaviour of the Covid-19 virus and further the rapidity of a global vaccination programme. For this screening platform, an international collaborative […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of anti-certolizumab pegol inhibitory antibodies to support the development of assays for therapeutic drug monitoring of tumor necrosis factor (TNF) alpha inhibitors. By extending its offering to include anti-certolizumab […]
New MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits combined with automation platform brings streamlined sample prep, faster testing and < 0.1ppb result sensitivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the introduction of its MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits, Which will help food safety, quality and aquaculture labs simultaneously and […]
Strasbourg, France – ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2. “Highly sensitive and specific antibodies are critical for the development of diagnostics, therapeutics, and prophylactics to fight against COVID-19,” says Philippe Funfrock, Co-founder and President of ProteoGenix. “The […]
Today Genovis acquired all shares in the privately held company QED Bioscience Inc. (QED), based in San Diego, California, USA. Genovis is paying about SEK 20 million in cash for the acquisition, including transaction costs. With a broadened product selection and a larger market, the company believes that after the acquisition it will be well-positioned […]
OXGENE™ and The Native Antigen Company (NAC) today announced a collaboration to accelerate production of SARS-CoV-2 (COVID-19) reagents by combining OXGENE’s proprietary Adenoviral Protein Machine technology with NAC’s antigen development expertise. Together, OXGENE™ and NAC will develop high purity proteins at scale for the urgently-needed development of diagnostics and vaccines. OXGENE™ and The Native Antigen […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
